Yea Christopher bought KALV
July 8, 2025 · Form 4 insider transaction
Yea Christopher bought 60,000 shares of KalVista Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Shares earned upon the vesting of a percentage of the performance stock units ("PSUs") granted to the Reporting Person on January 11, 2023. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of performance data metric goals ("Performance Metrics"). 100% of the total number of shares subject to the PSUs vested on July 8, 2025, upon Performance Metrics achieved.; Each PSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.